Trinity Capital Inc is an internally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, capital appreciation through investments across five distinct vertical markets. The company is focused on achieving its investment objective by operating as a specialty lending company that provides debt, including loans, equipment financings, and asset-based lending, to growth-oriented companies, including institutional investor-backed companies. Its investment portfolio mainly comprises private companies that have begun to have success selling their products to the market and need additional capital to expand their operations and sales.
Last trade$17.27
Day change-$0.225 (-1.29%)
Day range$17.21 – $17.70
Volume505,083
Market cap$1.73B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.73B
Price / earnings
12.46×
Price / book
1.87×
Price / sales
6.28×
EV / sales
10.01×
EV / EBITDA
15.54×
Profitability
Earnings per share
$1.40
Return on assets
6.79%
Return on equity
15.02%
Dividend yield
0%
Liquidity and leverage
Debt / equity
1.14×
Current ratio
3.52×
Quick ratio
3.52×
Cash ratio
0.05×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$401.04M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for TRIN, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Q2 FY2024 Jun 30, 2024
Q1 FY2024 Mar 31, 2024
Revenue
$85.59M
$75.47M
$76.09M
$60.09M
$82.11M
$56.81M
$54.64M
$39.8M
Cost of revenue
$24.77M
$24.1M
$18.04M
$17.66M
$0
$0
$0
$0
Gross profit
$60.81M
$51.37M
$58.05M
$42.43M
$82.11M
$56.81M
$54.64M
$39.8M
Selling, general and administrative
$1.25M
$1.22M
$1.79M
$2.03M
$1.96M
$1.3M
$1.34M
$720K
Research and development
—
—
—
—
—
—
—
—
Total operating expenses
$15.77M
$20.5M
$16.01M
$14.73M
$35.47M
$31.79M
$27.26M
$24.66M
Operating income
$45.04M
$30.87M
$42.04M
$27.7M
$46.64M
$25.02M
$27.38M
$15.15M
Interest expense
—
—
—
—
—
—
—
—
Income before taxes
$45.04M
$30.87M
$42.04M
$27.7M
$46.64M
$25.02M
$27.38M
$15.15M
Income taxes
$639K
$1.04M
$621K
$616K
$781K
$619K
$639K
$639K
Net income
$44.41M
$29.83M
$41.41M
$27.09M
$45.86M
$24.4M
$26.74M
$14.51M
Net income attributable to common shareholders
$44.41M
$29.83M
$41.41M
$27.09M
$45.86M
$24.4M
$30.83M
$14.51M
EBITDA
$45.04M
$30.87M
$42.04M
$27.7M
$65.69M
$41.89M
$41.27M
$27.29M
Basic earnings per share
$0.49
$0.36
$0.63
$0.43
$0.77
$0.45
$0.61
$0.31
Diluted earnings per share
$0.49
$0.36
$0.63
$0.43
$0.72
$0.43
$0.59
$0.30
Recent news
Company coverage with links to the original publishers.
Codexis, Inc. announced a $60 million senior secured term loan agreement with Trinity Capital Inc. to refinance existing debt and provide capital flexibility for advancing its ECO Synthesis Manufacturing Platform for siRNA therapeutic manufacturing. The new facility offers 48 months of interest-only payments followed by a 12-month amortization period beginning November 2030, with post-closing outstanding debt of $42.5 million.
Trinity Capital (TRIN) reported Q3 2026 earnings of $0.52 per share, matching consensus estimates, with revenues of $98.39 million exceeding expectations by 3.79%. The stock has outperformed the S&P 500 by 5.8% year-to-date. However, the company received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, suggesting near-term performance in line with the market. The Financial - SBIC & Commercial Industry ranks in the top 32% of Zacks industries.
New Mountain Finance (NMFC) reported Q3 2026 earnings of $0.26 per share, matching consensus estimates but missing revenue expectations at $60.41 million. The company has underperformed the S&P 500 by 23.7% year-to-date. Despite the miss, NMFC maintains a Zacks Rank #2 (Buy) rating based on favorable estimate revision trends. Trinity Capital (TRIN), another business development company in the same industry, is expected to report results on November 4.
Route 92 Medical, a neurovascular medical technology company, secured a $100 million senior secured debt facility from Trinity Capital Inc. to support its growth strategy and meet strong product demand. The company's integrated neurovascular platform features proprietary technologies including Tenzing delivery catheters and Monopoint, with products like HiPoint 88 receiving FDA clearance for acute ischemic stroke treatment.
Trinity Capital Inc. (NASDAQ: TRIN) announced a monthly regular dividend of $0.17 per share for July, August, and September 2026. The dividend remains consistent with distributions from the first six months of 2026, and shareholders have received consistent or increased dividends for over six consecutive years. The company aims to distribute 90-100% of its taxable quarterly income to qualify as a regulated investment company.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.17 per share
Declared
Sep 16, 2026
Ex-dividend
Dec 11, 2026
Pay date
Dec 31, 2026
Ex-dividend
Amount / share
Pay date
Type
Nov 13, 2026
$0.17
Nov 30, 2026
recurring
Oct 15, 2026
$0.17
Oct 30, 2026
recurring
Sep 10, 2026
$0.17
Sep 30, 2026
recurring
Aug 14, 2026
$0.17
Aug 31, 2026
recurring
Jul 15, 2026
$0.17
Jul 31, 2026
recurring
Stock splits
Historical share-structure events and their execution dates.